The research of nanoparticles as gene vector for tumor gene therapy

Critical Reviews in Oncology/Hematology

Volumn 89, Issue 3, 2014, Pages 352-357

  Sun, Nian feng ^a,b   Liu, Zhan ao ^a,b   Huang, Wen bai ^a,b   Tian, Ai ling ^a,b   Hu, San yuan ^a  

^a SHANDONG UNIVERSITY   (China)

^b JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Gene vectors; Nanoparticles; Transfection efficiency; Tumor

Indexed keywords

GENE VECTORS; NANOPARTICLES; TRANSFECTION EFFICIENCY; TUMOR;

GENETIC THERAPY; GENETIC VECTORS; GOLD; HUMANS; MAGNETICS; NANOPARTICLES; NEOPLASMS;

EID: 84893771688     PISSN: 10408428     EISSN: 18790461     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2013.10.006     Document Type: Review

References (61)

1. Lindgren M., Rosenthal-Aizman K., Saar K., et al. Overcoming metho-trexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide. Biochem Pharmacol 2006, 71(4):416-425.
2. Namiki Y., Namiki T., Yoshida H., et al. A novel magnetic crystal-lipid nanostructure for magnetically guided in vivo gene delivery. Nat Nanotechnol 2009, 4(9):598-606.
3. Calvom C., Thrashier A., Mavilo F., et al. The future of gene therapy. Nature 2004, 427(6977):779-781.
4. Yang Y., Xu Z., Jiang J., et al. Poly (imidazole/DMAEA) phosphazene/DNA self-assembled nanoparticles for gene delivery: synthesis and in vitro transfection. J Control Release 2008, 127(3):273-279.
5. Zhang S., Zhao B., Jiang H., et al. Cationic lipids and polymers mediated vectors for delivery of siRNA. J Control Release 2007, 123(1):1-10.
6. Ma B., Zhang S., Jiang H., et al. Lipoplex morphologies and their influences on transfection efficiency in gene delivery. J Control Release 2007, 123(3):184-194.
7. Sakaguchi N., Kojima C., Harada A., et al. Enhancement of transfection activity of lipoplexes by complexation with transfer-rin-bearing fusogenic polymer-modified liposomes. Int J Pharm 2006, 325(1-2):186-190.
8. Zhang Y., Li M., Sun J., et al. DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery. Int J Pharm 2010, 390(2):198-207.
9. Chowdhury E.H., Kunou M., Nagaoka M., et al. High-efficiency gene delivery for expression in mammalian cells by nanoprecipitates of Ca-Mg phosphate. Gene 2004, 341:77-82.
10. Roy I., Ohulchanskyy T.Y., Bharali D.J., et al. Optical tracking of organically modified silica nanoparticles as DNA carriers: a nonviral, nanomedicine approach for gene delivery. Proc Natl Acad Sci USA 2005, 102(2):279-284.
11. Qin F., Zhou Y., Shi J., et al. A DNA transporter based on mesoporous silica nanospheres mediated with polycation poly (allylamine hydrochloride) coating on mesopore surface. Biomed Mater Res 2009, 90A:333.
12. Mahmoudi M., Simchi A., Imani M., et al. Super paramagnetic iron oxide nanoparticles with rigid cross-linked polyethylene glycol fumarate coating for application in imaging and drug delivery. J Phys Chem 2009, 113(19):8124-8131.
13. Qureshi H.Y., Ahmad R., Zafarullah M. High-efficiency transfection of nucleic acids by the modified calcium phosphate precipitation method in chondrocytes. Anal Biochem 2008, 382(2):138-140.
14. Sandhu K.K., McIntosh C.M., Simard J.M., et al. Gold nanoparticles mediated transfection of mammalian cells. Bioconjugate Chem 2002, 13(1):3-6.
15. Saccardo P., Villaverde A., González-Montalbán N. Peptide-mediated DNA condensation for non-viral gene therapy. Biotechnol Adv 2009, 27(4):432-438.
16. Jackson D.A., Juranek S., Lipps H.J. Designing nonviral vectors for efficient gene transfer and long-term gene expression. Mol Ther 2006, 14(5):613-626.
17. Pack D.W., Hoffman A.S., Pun S., et al. Design and development of polymers for gene delivery. Nat Rev Drug Discov 2005, 4(7):581-593.
18. Steele T.W.J., Shier W.T. Dendrimeric alkylated polyethylenimine nano-carriers with acid-cleavable outer cationic shells mediate improved transfection efficiency without increasing toxicity. Pharm Res 2010, 27(4):683-698.
19. Yu K.-F., Zhang W.-Q., Luo L.-M., et al. The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation. Int J Nanomedicine 2013, 8:2473-2485.
20. Chen J., Yu Z., Chen H., Gao J., Liang W. Transfection efficiency and intracellular fate of polycation liposomes combined with protamine. Biomaterials 2011, 32:1412-1418.
21. Santos J.L., Oliveira H., Pandita D., et al. Functionalization of poly (amidoamine) dendrimers with hydrophobic chains for improved gene delivery in mesenchymal stem cells. J Control Release 2010, 144(1):55-64.
22. Xiaohu G., Liqiang X., Fang T., Yi D. Au-Ag alloy nanoporous nanotubes. Nano Res 2009, 2(5):386-393.
23. Fan Y., Du W., He B., et al. The reduction of tumor interstitial fluid pressure by liposomal imatinib and its effect on combination therapy with liposomal doxorubicin. Biomaterials 2013, 34(9):2277-2288.
24. Yamano S., Dai J., Yuvienco C., Khapli S., Moursi A.M., Montclare J.K. Modified Tat peptide with cationic lipids enhances gene transfection efficiency via temperature-dependent and caveolae-mediated endocytosis. J Control Release 2011, 152:278-285.
25. Xiaohu G., Xiao C., Yi D. Platinum-decorated Au porous nanotubes as highly efficient catalysts for formic acid electro-oxidation. ChemPhysChem 2010, 11(4):841-846.
26. Luo L.M., Huang Y., Zhao B.X., et al. Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxel. Biomaterials 2013, 34(4):1102-1114.
27. Al-Jamal W.T., Al-Ahmady Z.S., Kostarelos K. Pharmacokinetics & tissue distribution of temperature-sensitive liposomal doxorubicin in tumor-bearing mice triggered with mild hyperthermia. Biomaterials 2012, 33(18):4608-4617.
28. Yingwen C., Cuicui Q., Houyi M., Xiaoka Z., Xiaohu G. Unusual corrosion process of gold nanoplates and the mechanism study. Nanoscale 2010, 2(5):685-688.
29. Islam M.A., Yun C.H., Choi Y.J., et al. Accelerated gene transfer through a polysorbitol-based transporter mechanism. Biomaterials 2011, 32:9908-9924.
30. Xingbo G., Rongyue W., Pengpeng L., Yi D. Platinum-decorated nanoporous gold leaf for methanol electrooxidation. Chem Mater 2007, 19(24):5827-5829.
31. Vighi E., Montanari M., Hanuskova M., Iannuccelli V., Coppi G., Leo E. Design flexibility influencing the in vitro behavior of cationic SLN as a nonviral gene vector. Int J Pharm 2013, 440:161-169.
32. Chan C.L., Majzoub R.N., Shirazi R.S., et al. Endosomal escape and transfection efficiency of PEGylated cationic liposome-DNA nanoparticles prepared with an acid-labile PEG-lipid. Biomaterials 2012, 33:4928-4935.
33. Kaul G., Amiji M. Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies. Pharm Res 2005, 22(6):951-961.
34. Dai W., Yang T., Wang Y., Peptide PHSCNK., et al. as an integrin α5β1 antagonist targets stealth liposomes to integrin-overexpressing melanoma. Nanomedicine 2012, 8(7):1152-1161.
35. Balogh L., Nigavekar S.S., Nair B.M. Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models. Nanomedicine 2007, 3(4):281-296.
36. 4 enhance docetaxel-induced prostate cancer cell death. Int J Nanomedicine 2013, 8:3151-3160.
37. Niraula S., Tannock I.F. Broadening horizons in medical management of prostate cancer. Acta Oncol 2011, 50(Suppl 1):141-147.
38. Yang S.Y., Sun J.S., Liu C.H. Ex vivo magnetofection with magnetic nanoparticles: a novel platform for nonviral tissue engineering. Artif Organs 2008, 32(3):195-204.
39. 4 nanoparticles. Int J Nanomedicine 2011, 6:1929-1935.
40. Harada M., Iwata C., Saito H., et al. NC-6301, a polymeric micelle rationally optimized for effective release of docetaxel, is potent but is less toxic than native docetaxel in vivo. Int J Nanomedicine 2012, 7:2713-2727.
41. 4 nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance. Int J Nanomedicine 2012, 7:2261-2269.
42. Dobson J. Magnetic micro-and nano-particle-based targeting for drug and gene delivery. Gene Ther 2006, 1(1):31-37.
43. MacKenzie L., McCall P., Hatziieremia S., et al. Nuclear factor κB predicts poor outcome in patients with hormone-naive prostate cancer with high nuclear androgen receptor. Hum Pathol 2012, 43(9):1491-1500.
44. Amstad E., Reimhult E. Nanoparticle actuated hollow drug delivery vehicles. Nanomedicine (Lond) 2012, 7(1):145-164.
45. Wang Z.Y., Wang L., Zhang J., et al. A study on the preparation and characterization of plasmid DNA and drug-containing magnetic nanoliposomes for the treatment of tumors. Int J Nanomed 2011, (6):871-875.
46. 4 nanoparticles combined with chemotherapy and hyperthermia to over-come multidrug resistance. Int J Nanomedicine 2012, 7:2261-2269.
47. Thu M.S., Bryant L.H., Coppola T., et al. Self-assembling nanoparticles by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging. Nat Med 2012, 18:463-467.
48. 4-dextran-anti-β-human chorionic gonadotropin, a new generation choriocarcinoma-specific gene vector. Int J Nanomedicine 2011, (6):285-294.
49. Aljarrah K., Mhaidat N.M., Al-Akhras M.A., et al. Magnetic nanoparticles sensitize MCF-7 breast cancer cells to doxorubicin-induced apoptosis. World J Surg Oncol 2012, 10:62.
50. Bhattarai S.R., Kim S.Y., Jang K.Y. N-hexanoyl chitosan-stabilized magnetic nanoparticles: enhancement of adenoviral-mediated gene expression both in vitro and in vitro. Nanomedicine 2008, 4(2):146-154.
51. Hu S.H., Liao B.J., Chiang C.S., Chen P.J., Chen I.W., Chen S.Y. Core-shell nanocapsules stabilized by single-component polymer and nanoparticles for magneto-chemotherapy/hyperthermia with multiple drugs. Adv Mater 2012, 24(27):3627-3632.
52. Cheng X., Darong Y., Lin M., et al. Encapsulating gold nanoparticles or nanorods in graphene oxide shells as a novel gene vector. ACS Appl Mater Interfaces 2013, 5(7):2715-2724.
53. Kim C., Agasti S., Zhu Z., Isaacs L., Rotello V.M. Recognition-mediated activation of therapeutic gold nanoparticles inside living cells. Nat Chem 2010, 2(11):962-966.
54. Rosi N.L., Giljohann D.A., Thaxton C.S., Lytton-Jean A.K., Han M.S., Mirkin C.A. Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 2006, 312(5):1027-1030.
55. Sharma J., Chhabra R., Cheng A., Brownell J., Liu Y., Yanl H. Control of self-assembly of DNA tubules through integration of gold nanoparticles. Science 2009, 323(1):112-116.
56. Kim B., Han G., Toley B.J., Kim C.-K., Rotello V.M., Forbes N.S. Tuning payload delivery in tumour cylindroids using gold nanoparticles. Nat Nanotechnol 2010, 5(6):465-472.
57. Shan Y., Luo T., Peng C., et al. Gene delivery using dendrimer-entrapped gold nanoparticles as nonviral vectors. Biomaterials 2012, 33(10):3025-3035.
58. Peng G., Tisch U., Adams O., et al. Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nat Nanotechnol 2009, 4(10):669-673.
59. Noh S., Kim W., Kim S., Kim J., Baek K., Oh Y. Enhanced cellular delivery and transfection efficiency of plasmid DNA using positively charged biocompatible colloidal gold nanoparticles. Biochim Biophys Acta 2007, 5:747-752.
60. Note C., Kosmella S., Koetz J. Poly(ethyleneimine) as reducing and stabilizing agent for the formation of gold nanoparticles in w/o microemulsions. Colloids Surf, A 2006, (1-3):150-156.
61. Estrada L.C., Gratton E. 3D nanometer images of biological fibers by directed motion of gold nanoparticles. Nano Lett 2011, 11(11):4656-4660.